Results 101 to 110 of about 9,024 (223)

Drug-induced torsades de pointes in an underserved urban population. Methadone: is there therapeutic equipoise? [PDF]

open access: yes, 2016
BACKGROUND Although it has been well established that methadone use can result in prolonged QTc/torsades de pointes (TdP) and has been labeled as one of the main drugs that cause TdP, it is still prescribed indiscriminately, and several cases of ...
Garcia, Mario J   +21 more
core   +1 more source

Kidney supportive care in Australia and New Zealand: an Australian and New Zealand Society of Nephrology (ANZSN) and Australian and New Zealand Society of Palliative Medicine (ANZSPM) guidance document

open access: yesInternal Medicine Journal, Volume 56, Issue S2, Page 4-48, June 2026.
The purpose of this document is to provide a summary of the current expert opinion and recent literature for clinicians, Indigenous health workers and patient advocates interested in Kidney Supportive Care (KSC) in Australia and New Zealand. Our purpose is not to duplicate the recently released International Society of Nephrology (ISN) KSC/Conservative
Kathryn Ducharlet   +23 more
wiley   +1 more source

Allongement de l’intervalle QT et torsades de pointes associés à la prise de méthadone

open access: yes, 2015
Résumé Objectif : Présenter un cas d’allongement de l’intervalle QT et de torsades de pointes à la suite de la prise de hautes doses de méthadone. Résumé du cas : Il s’agit d’un patient de 41 ans atteint du virus de l’immunodéficience humaine qui prend ...
Bilodeau, Sarah, Carier, Isabelle
core  

Acquired long QT interval complicated with Torsades de Pointes as presentation of a pheochromocytoma in a paediatric patient: a case report

open access: yes, 2015
Torsades de Pointes is an extremely rare arrhythmia in children associated to LQT syndrome. Pheochromocytomas are also extremely rare tumours in the paediatric age.
Gonzalez, Maria Cecilia   +2 more
core   +1 more source

Interactions médicamenteuses et risque de torsades de pointes

open access: yes, 2015
Résumé: Objectif : Certaines études pharmacoépidémiologiques font état de plus de 10 000 morts annuellement au Canada à la suite de l’utilisation inappropriée de médicaments.
Hreiche, Raymond, Turgeon, Jacques
core  

Case report : reversible QT prolongation with torsades de pointes in a patient with pimozide intoxication

open access: yes, 1995
Pimozide is a diphenylpiperidine neuroleptic with well characterized cardiovascular side effects including QT prolongation. So far, life-threatening cardiac arrhythmias, in particular torsades de pointes, have not been described in patients treated with ...
Kupferschmidt, H.   +5 more
core  

Flecainide associated torsade de pointes: A potential case of reverse use dependence

open access: yesJournal of Research in Medical Sciences, 2013
Flecainide has been known to cause torsades de pointes (TdP) in patients with structural heart disease and its mechanism has been attributed to use-dependency.
Kevin Hayes   +5 more
doaj  

Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study

open access: yesDrug, Healthcare and Patient Safety, 2011
Matthew J Hafermann1, Rocsanna Namdar2, Gretchen E Seibold2,3, Robert Lee Page 2nd2,31University of Washington Medical Center, Department of Pharmacy, Seattle, WA; 2University of Colorado Anschutz Medical Campus, School of Pharmacy, Aurora, CO ...
Hafermann MJ   +3 more
doaj  

Torsades de pointes following clarithromycin treatment

open access: yes, 2013
A 75-year-old woman presenting with pre-syncope, shortness of breath and nausea was admitted to the emergency department following treatment with clarithromycin. Shortly after admission she developed a prolonged QT interval leading to torsades de pointes
Vieweg, W Victor R   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy